PARIS or PAtch RIng Study: A Trial to Evaluate NuvaRing Versus OrthoEvra
Status:
Completed
Trial end date:
2006-12-01
Target enrollment:
Participant gender:
Summary
This is an open-label prospective, multicenter, randomized trial to compare continuation
rates into the fourth cycle of women using either the NuvaRing or OrthoEvra. Five hundred
women will be recruited at 9 centers nationwide to be randomly assigned to use either the
NuvaRing or OrthoEvra for four months. Women must either be on the pill or have recently
stopped the pill and be relatively satisfied with oral contraceptive use to qualify for
enrollment. Two visits and two phone calls will be required.